Affiliations 

  • 1 Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK
  • 2 Dr. John T. Macdonald Foundation, John P. Hussman Institute for Human Genomics, University of Miami, Miami, FL 33136, USA
  • 3 Laboratorio di Epigenetica, Dipartimento Medicina Riabilitativa NeuroMotoria - MeRiNM, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, 27100, Italy
  • 4 Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, 150 06 Praha, Czechia
  • 5 Unit of Rare Neurological Diseases, Department of Clinical Neurosciences, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, 20133, Italy
  • 6 Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, 80131 Naples, Italy
  • 7 Division of Neurology, Department of Medicine, Al-Jahra Hospital, Al-Jahra, 00020, Kuwait
  • 8 Department of Biostatistics and Computational Biology, University of Rochester, Rochester, New York 14642, USA
  • 9 Clinical Hospital of Ribeirão Preto, Department of Neurosciences and Behaviour Sciences, University of São Paulo, Ribeirão Preto, 14015-010, Brazil
  • 10 Nord/Est/Ile-de-France Neuromuscular Diseases Reference Center, Pitié-Salpêtrière Hospital, APHP, 75013 Paris, France
  • 11 IRCCS Mondino Foundation, 27100 Pavia, Italy
  • 12 Charité University Medicine Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Department of Neurology and Experimental Neurology, Berlin, 10117, Germany
  • 13 Department of Neurology, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany
  • 14 Department of Neurology, Beilinson Hospital, Rabin Medical Center, Petah Tikva, 4941492, Israel
  • 15 Department of Neurology, University Hospital rechts der Isar, School of Medicine and Health, Technical University Munich, München, 81675, Germany
  • 16 Center for Genomics and Transcriptomics Tübingen and Zentrum für Humangenetik Tübingen, 72076 Tübingen, Germany
  • 17 Department of Neurology and Hertie Institute for Clinical Brain Research (HIH), University of Tübingen, 72076 Tübingen, Germany
  • 18 Department of Neurology, University of Rochester, Rochester, NY 14642, USA
  • 19 Unit of Medical Genetics and Neurogenetics, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, 20133, Italy
  • 20 Department of Neurology, Neurocenter of Southern Switzerland EOC, Ospedale Regionale di Lugano, via Tesserete 46, Lugano, 6900, Switzerland
  • 21 Service de neurologie, Centre de référence des maladies neuromusculaires, Hôpitaux Universitaires de Strasbourg, Strasbourg, 67091, France
  • 22 Clinical Genetics, NHS Grampian, Aberdeen, AB15 6RE, UK
  • 23 Department of Neurology, The Walton Centre, Liverpool, L9 7LJ, UK
  • 24 Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow G51 4TF, UK
  • 25 Raphael Recanati Genetic Institute, Rabin Medical Center - Beilinson Hospital, Petah Tikva 4941492, Israel
  • 26 Service de Génétique, Centre Hospitalier Universitaire Caen Normandie, Caen, 14000, France
  • 27 Neuromuscular Unit, Department of Neurology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, 1827  Turkey
  • 28 Department of Molecular Biology and Genetics, Center for Life Sciences and Technologies, Bogazici University, 34342 Istanbul, Turkey
  • 29 Neuromuscular Unit, Neurology Department, Istanbul Faculty of Medicine, Istanbul University, Istanbul, 34093, Turkey
  • 30 Kuwait Medical Genetics Centre, Sabah Hospital, Kuwait City, Kuwait
  • 31 Wessex Neurological Centre, University Hospital Southampton NHS Foundation Trust. Southampton, SO16 6YD, UK
  • 32 Molecular Medicine Laboratory and Department of Neurology, Concord Repatriation General Hospital, Concord Clinical School, The University of Syndey, Concord, NSW 2006, Australia
  • 33 Northcott Neuroscience Laboratory, ANZAC Research Institute, Sydney Local Health District, Concord and School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2050, Australia
  • 34 Department of Medical Genetics, Koc University School of Medicine (KUSOM), Istanbul, 34010, Turkey
  • 35 Department of Neurology, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
  • 36 Department of Medical and Surgical Sciences, Institute of Neurology, University Magna Graecia, Catanzaro, 88100  Italy
  • 37 Institute for Biomedical Research and Innovation (IRIB), Department of Biomedical Sciences, National Research Council (CNR), Mangone (CS), 87050, Italy
  • 38 Department of Medical Genetics, Telemark Hospital Trust, Skien, 3710  Norway
  • 39 Neurology Clinic, University Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, 11000  Serbia
  • 40 Human Inherited Neuropathies Unit, Division of Neuroscience, Institute of Experimental Neurology, IRCCS Ospedale San Raffaele, Milan, 20132  Italy
  • 41 Neuromuscular Repair Unit, Division of Neuroscience, IRCCS Ospedale San Raffaele, Milan, 20132  Italy
  • 42 Department of Neurology, Taipei Veterans General Hospital, Taipei, 11217  Taiwan
  • 43 Koç University, School of Medicine, Suna and İnan Kıraç Foundation, Neurodegeneration Research Laboratory (NDAL), Research Center for Translational Medicine, Istanbul, 34010  Turkey
  • 44 Department of Neurology and Psychiatry, Assiut University Hospital, Assiut, 71515  Egypt
  • 45 Department of Neurology, Neuromuscular Diseases Unit, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, 08193  Spain
  • 46 Department of Neurology, University Hospitals Leuven, Leuven, 3000  Belgium
  • 47 Neurology Department, La Fe Health Research Institute (IISLAFE), Neuromuscular Research Unit, Valencia, 46026  Spain
  • 48 Friedrich Baur Institute at the Department of Neurology, LMU University Hospital, LMU Munich, München, 80336  Germany
  • 49 Department of Neurology, Third Xiangya Hospital, Central South University, Changsha 410013, China
  • 50 Department of Neurology, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA
Brain, 2025 Feb 13.
PMID: 39938083 DOI: 10.1093/brain/awaf021

Abstract

Biallelic loss-of-function mutations in the sorbitol dehydrogenase (SORD) gene cause the most common recessive type of Charcot-Marie-Tooth disease (CMT), CMT-SORD. However, the full genotype-phenotype spectrum and progression of the disease remain to be defined. Notably, a multicenter phase 2/3 study to test the efficacy of govorestat (NCT05397665), a new aldose reductase inhibitor, is currently ongoing. Diagnosing CMT-SORD will become imperative when disease-modifying therapies become available. In this cross-sectional multicentre study, we identified 144 patients from 126 families, including 99 males (69%) and 45 females (31%). Patients represented multiple ancestries, including European, Hispanic, Chinese, Near Eastern, and Northern African. We confirmed c.757delG (p.Ala253GlnfsTer27) as the most common pathogenic allele, followed by c.458C>A (p.Ala153Asp), while other variants were identified mostly in single cases. The average sorbitol level in CMT-SORD patients was significantly higher compared to controls and heterozygous carriers, independently from serum storage duration, sex, or variant type. Two-thirds of cases were diagnosed with CMT2 while one-third had distal hereditary motor neuropathy (dHMN). Disease onset was usually in the second decade of life. Although foot dorsiflexion was the most affected muscle group, dorsal and plantar flexion had a similar degree of weakness in most cases (difference of Medical Research Council score ≤ 1). One fourth of patients used ankle foot orthoses, usually in their 30s, but most patients maintained independent ambulation later in life. Nerve conduction studies (NCS) were suggestive of a motor predominant axonal neuropathy, with reduced conduction velocities in the intermediate range in one fourth of the cases. Sensory conductions in the upper limbs appeared more frequently affected than in the lower limbs. Foot dorsiflexion and plantar flexion decreased significantly with age. Male sex was significantly associated with the severity of distal lower limb weakness (plantar flexion) and a larger change over time (dorsiflexion). In conclusion, CMT-SORD is a frequent recessive form of axonal, motor predominant CMT, with prominent foot dorsiflexion and plantar flexion involvement. Fasting serum sorbitol is a reliable biomarker of the condition that can be utilized for pathogenicity assessment of identified rare SORD variants.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.